Nautilus Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
4,297
+37
+0.9% +$9.76K 0.69% 39
2026
Q2
$1.09M Hold
4,260
– – 0.65% 40
2026
Q1
$1.04M Sell
4,260
-90
-2% -$21K 0.71% 37
2025
Q4
$900K Sell
4,350
-99
-2% -$19.6K 0.59% 45
2025
Q3
$825K Sell
4,449
-154
-3% -$26.4K 0.56% 48
2025
Q2
$703K Sell
4,603
-35
-0.8% -$5.38K 0.52% 54
2025
Q1
$769K Hold
4,638
– – 0.64% 48
2024
Q4
$671K Buy
+4,638
New +$719K 0.53% 54

Other funds holding JNJ

Nautilus Advisors's JNJ Position: Q3 2026 in Review

Nautilus Advisors increased its Johnson & Johnson (JNJ) stake by 0.87% in Q3 2026, buying an estimated $9.76K and bringing the position to 4,297 shares worth $1.14M. The position accounts for 0.69% of the portfolio, ranked #39.

Nautilus Advisors first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 267 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Nautilus Advisors held 4,297 shares of Johnson & Johnson worth $1.14M as of Q3 2026.
  • Nautilus Advisors bought 37 Johnson & Johnson shares in Q3 2026, an estimated $9.76K.
  • Johnson & Johnson made up 0.69% of Nautilus Advisors's portfolio in Q3 2026, its #39 holding.
  • Nautilus Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 267 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Nautilus Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.